Pilot Trial: Comparison of Flow Patterns

NCT ID: NCT02288871

Last Updated: 2018-03-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-10-31

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine why sutureless aortic bioprostheses apparently offer better haemodynamic properties compared to sewed-in aortic bioprostheses in patients who underwent aortic valve replacement.

Our approach to address this question is the combination of clinical data with the application of specifically validated experimental and computer based analyses to compare the performance of these valves under patient-specific conditions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aortic Valve Stenosis Aortic Valve Insufficiency

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

"Sutureless" valve

Patients who underwent aortic valve replacement with a "sutureless" aortic valve.

An echocardiogram and a cardiac CT-scan will be conducted.

Group Type OTHER

Cardiac CT-scan

Intervention Type RADIATION

ECG gated CT angiography of the heart will be performed on a 128-slice dual-source and two Stellar detectors CT system with retrospective ECG-gating (Siemens/SOMATOM Definition Flash - Siemens, Germany, 100kV, 395.75 mAs).

In details, multi-phase images will be acquired to reconstruct between 10 and 100% of the cardiac cycle (10% increments) with a slice thickness of 1 mm. Examination will include left ventricular outflow tract, aortic root, coronary sinus, ascending aorta together with the prosthetic valves.

"Sewed-in" valve

Patients who underwent aortic valve replacement with a "sewed-in" aortic valve. An echocardiogram and a cardiac CT-scan will be conducted.

Group Type OTHER

Cardiac CT-scan

Intervention Type RADIATION

ECG gated CT angiography of the heart will be performed on a 128-slice dual-source and two Stellar detectors CT system with retrospective ECG-gating (Siemens/SOMATOM Definition Flash - Siemens, Germany, 100kV, 395.75 mAs).

In details, multi-phase images will be acquired to reconstruct between 10 and 100% of the cardiac cycle (10% increments) with a slice thickness of 1 mm. Examination will include left ventricular outflow tract, aortic root, coronary sinus, ascending aorta together with the prosthetic valves.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cardiac CT-scan

ECG gated CT angiography of the heart will be performed on a 128-slice dual-source and two Stellar detectors CT system with retrospective ECG-gating (Siemens/SOMATOM Definition Flash - Siemens, Germany, 100kV, 395.75 mAs).

In details, multi-phase images will be acquired to reconstruct between 10 and 100% of the cardiac cycle (10% increments) with a slice thickness of 1 mm. Examination will include left ventricular outflow tract, aortic root, coronary sinus, ascending aorta together with the prosthetic valves.

Intervention Type RADIATION

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient underwent open aortic valve replacement with either an Edwards Magna Ease or an Edwards Intuity valve
* Implanted valve size 23mm
* Surgical access via full sternotomy or hemisternotomy
* Intuity Valve System implanted by one of the clinical investigators of the TRITON trial (http://clinicaltrials.gov/show/NCT01445171) at the Medical University of Vienna
* Post-operative ejection fraction ≥50%
* Sinus-Rhythm
* Ability to understand and comply with study procedures
* Signed informed consent

Exclusion Criteria

* Under 18 years of age
* Emergency surgery
* Pregnancy
* Previous aortic root replacement
* Previous aortic valve replacement
* Previous or concomitant root enlargement
* Previous or concomitant repair of the ascending aorta
* Paravalvular leakage
* Ectasia of the ascending aorta
* Previous or concomitant myomectomy
* Concomitant replacement or repair of valves other than aortic
* Usage of more than 3 sutures for implantation of the Intuity Valve System
* Heavily calcified aortic root
* Glomerular filtration rate (GFR) \< 30 ml/min
* Inability to understand or comply with study procedures
* Known allergic reaction to iodinated, non-ionic contrast agents
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University College, London

OTHER

Sponsor Role collaborator

Medical University of Vienna

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Alfred A Kocher, MD

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alfred Kocher, MD

Role: PRINCIPAL_INVESTIGATOR

Division of Cardiac Surgery, Department of Surgery, Medical University of Vienna

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medical University of Vienna

Vienna, , Austria

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Austria

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Claus Rath, MD

Role: CONTACT

0043-1-40400-69660

Martin Andreas, MD

Role: CONTACT

0043-1-40400-69660

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Claus Rath, MD

Role: primary

0043-1-40400-69660

Alfred Kocher, MD

Role: backup

0043-1-40400-69660

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1790/2013-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.